PP_1170x120_10-25-21

Clinical and Translational Science

New clinical trial data demonstrates BD Libertas Wearable Injector as a drug delivery system

New clinical trial data demonstrates BD Libertas Wearable Injector as a drug delivery system

FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Co.) announced on Wednesday the publication of the results from a 52-subject human clinical trial with the BD Libertas Wearable Injector. The subcutaneous drug delivery system, currently in final phases of development, is designed as ready to use and to deliver drugs such as biologics with viscosities

Adheris Health